SARAH NORRIS: Open Payments
NPI 1407577612 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 25 payments from 13 companies in 2025. Trend: 2023 $1,187 · 2024 $692 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Valencia Technologies Corporation | 1 | $187 |
| Astellas Pharma US Inc | 1 | $98 |
| 180 Medical, Inc. | 4 | $90 |
| UROGEN PHARMA, INC. | 3 | $71 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Janssen Biotech, Inc. | 2 | $41 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| ABBVIE INC. | 2 | $33 |
| Smith+Nephew, Inc. | 1 | $21 |
Products named: eCoin Device Kit, XTANDI, JOURNAVX, JELMYTO, ERLEADA, GEMTESA, GENTLECATH, GENTLECATH GLIDE.
Industry payments across IA — which companies pay providers there.
